{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:55:11Z","timestamp":1781009711889,"version":"3.54.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T00:00:00Z","timestamp":1498608000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatology Communications"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:p>Idiosyncratic drug\u2010induced liver injury (iDILI) is a rare adverse drug reaction that occasionally leads to acute liver failure or even death. An aging population that uses more drugs, a constant influx of newly developed drugs, and a growing risk from herbal and dietary supplements of uncertain quality can lead to an increase in iDILI. Antimicrobials, central nervous system agents, and herbal and dietary supplements are the most common causes of iDILI in developed countries. iDILI is still a diagnosis of exclusion, and thus careful history taking and thorough work\u2010ups for competing etiologies, such as acute viral hepatitis, autoimmune hepatitis, and others, are essential. The pathogenesis of iDILI is not clear and includes a mix of host reactions, drug metabolites, and environmental factors. Immediate cessation of the suspected offending drug is key to preventing or minimizing progressive damage. No definitive therapies for iDILI are available, and the treatments remain largely supportive. (<jats:italic toggle=\"yes\">Hepatology Communications<\/jats:italic> 2017;1:494\u2013500)<\/jats:p>","DOI":"10.1002\/hep4.1064","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T11:12:36Z","timestamp":1498648356000},"page":"494-500","source":"Crossref","is-referenced-by-count":31,"title":["Idiosyncratic drug\u2010induced liver injury: A short review"],"prefix":"10.1097","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8439-6660","authenticated-orcid":false,"given":"Yo\u2010ichi","family":"Yamashita","sequence":"first","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medical Sciences,Kumamoto University,Kumamoto,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medical Sciences,Kumamoto University,Kumamoto,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Mima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medical Sciences,Kumamoto University,Kumamoto,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medical Sciences,Kumamoto University,Kumamoto,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medical Sciences,Kumamoto University,Kumamoto,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Chikamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medical Sciences,Kumamoto University,Kumamoto,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medical Sciences,Kumamoto University,Kumamoto,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,6,28]]},"reference":[{"key":"hep41064-bib-0001-20240114","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","year":"2002","journal-title":"Ann Intern Med"},{"key":"hep41064-bib-0002-20240114","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug\u2010induced liver injury in the general population of Iceland","volume":"144","year":"2013","journal-title":"Gastroenterology"},{"key":"hep41064-bib-0003-20240114","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1378\/chest.128.1.116","article-title":"Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7\u2010year evaluation from a public health tuberculosis clinic","volume":"128","year":"2005","journal-title":"Chest"},{"key":"hep41064-bib-0004-20240114","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0168-8278(92)90029-O","article-title":"Liver damage from flucloxacillin, cloxacillin and dicloxacillin","volume":"15","year":"1992","journal-title":"J Hepatol"},{"key":"hep41064-bib-0005-20240114","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00000542-198510000-00014","article-title":"Unexplained hepatitis following halothane","volume":"63","year":"1985","journal-title":"Anesthesiology"},{"key":"hep41064-bib-0006-20240114","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/hep.21324","article-title":"Determinants of the clinical expression of amoxicillin\u2010clavulanate hepatotoxicity: a prospective series from Spain","volume":"44","year":"2006","journal-title":"Hepatology"},{"key":"hep41064-bib-0007-20240114","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840080327","article-title":"Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases","volume":"8","year":"1988","journal-title":"Hepatology"},{"key":"hep41064-bib-0008-20240114","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ajg.2014.131","article-title":"ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug\u2010induced liver injury","volume":"109","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"hep41064-bib-0009-20240114","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/apt.12324","article-title":"Review article: prescribing medications in patients with cirrhosis \u2010 a practical guide","volume":"37","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"hep41064-bib-0010-20240114","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jhep.2002.30319","article-title":"Hepatotoxicity associated with nevirapine or efavirenz\u2010containing antiretroviral therapy: role of hepatitis C and B infections","volume":"35","year":"2002","journal-title":"Hepatology"},{"key":"hep41064-bib-0011-20240114","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/hep.22272","article-title":"Relationship between daily dose of oral medications and idiosyncratic drug\u2010induced liver injury: search for signals","volume":"47","year":"2008","journal-title":"Hepatology"},{"key":"hep41064-bib-0012-20240114","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/lt.20204","article-title":"Liver transplantation for acute liver failure from drug induced liver injury in the United States","volume":"10","year":"2004","journal-title":"Liver Transpl"},{"key":"hep41064-bib-0013-20240114","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.22895","article-title":"Phenotypic characterization of idiosyncratic drug\u2010induced liver injury: the influence of age and sex","volume":"49","year":"2009","journal-title":"Hepatology"},{"key":"hep41064-bib-0014-20240114","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/hep.26208","article-title":"High lipophilicity and high daily dose of oral medications are associated with significant risk for drug\u2010induced liver injury","volume":"58","year":"2013","journal-title":"Hepatology"},{"key":"hep41064-bib-0015-20240114","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity","volume":"4","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"hep41064-bib-0016-20240114","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug\u2010induced liver injury in the United States","volume":"135","year":"2008","journal-title":"Gastroenterology"},{"key":"hep41064-bib-0017-20240114","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/liv.12540","article-title":"Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug\u2010Induced Liver Injury Network (DILIN)","volume":"35","year":"2015","journal-title":"Liver Int"},{"key":"hep41064-bib-0019-20240114","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2010\u2010I. A novel method based on the conclusions of international consensus meetings: application to drug\u2010induced liver injuries","volume":"46","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"hep41064-bib-0020-20240114","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0895-4356(93)90102-7","article-title":"Causality assessment of adverse reactions to drugs\u2010\u2010II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge","volume":"46","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"hep41064-bib-0021-20240114","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510260319","article-title":"Development and validation of a clinical scale for the diagnosis of drug\u2010induced hepatitis","volume":"26","year":"1997","journal-title":"Hepatology"},{"key":"hep41064-bib-0022-20240114","first-page":"pii","article-title":"Drug induced liver injury: can biomarkers assist RUCAM in causality assessment?","volume":"18","year":"2017","journal-title":"Int J Mol Sci"},{"key":"hep41064-bib-0023-20240114","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug\u2010induced liver disorders. Report of an international consensus meeting","volume":"11","year":"1990","journal-title":"J Hepatol"},{"key":"hep41064-bib-0024-20240114","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1053\/j.gastro.2011.07.051","article-title":"Acute hepatitis E infection accounts for some cases of suspected drug\u2010induced liver injury","volume":"141","year":"2011","journal-title":"Gastroenterology"},{"key":"hep41064-bib-0025-20240114","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJMra1204512","article-title":"Hepatitis E","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"key":"hep41064-bib-0026-20240114","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0034-1375959","article-title":"Drug\u2010induced liver injury with autoimmune features","volume":"34","year":"2014","journal-title":"Semin Liver Dis"},{"key":"hep41064-bib-0027-20240114","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug\u2010induced liver injury","volume":"89","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"hep41064-bib-0028-20240114","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1211","article-title":"Hy's law: predicting serious hepatotoxicity","volume":"15","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"hep41064-bib-0029-20240114","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1038\/ajg.2010.287","article-title":"Single\u2010center experience with drug\u2010induced liver injury from India: causes, outcome, prognosis, and predictors of mortality","volume":"105","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"hep41064-bib-0030-20240114","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jhep.2010.04.029","article-title":"Cytokeratin 18\u2010based modification of the MELD score improves prediction of spontaneous survival after acute liver injury","volume":"53","year":"2010","journal-title":"J Hepatol"},{"key":"hep41064-bib-0031-20240114","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.gastro.2009.06.006","article-title":"Intravenous N\u2010acetylcysteine improves transplant\u2010free survival in early stage non\u2010acetaminophen acute liver failure","volume":"137","year":"2009","journal-title":"Gastroenterology"},{"key":"hep41064-bib-0032-20240114","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/hep.26001","article-title":"Intravenous N\u2010acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo\u2010controlled clinical trial","volume":"57","year":"2013","journal-title":"Hepatology"},{"key":"hep41064-bib-0033-20240114","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1212\/WNL.56.10.1405","article-title":"Effect of L\u2010carnitine treatment for valproate\u2010induced hepatotoxicity","volume":"56","year":"2001","journal-title":"Neurology"},{"key":"hep41064-bib-0034-20240114","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yrtph.2009.03.003","article-title":"Drug\u2010induced liver injury following positive drug rechallenge","volume":"54","year":"2009","journal-title":"Regul Toxicol Pharmacol"},{"key":"hep41064-bib-0035-20240114","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2014.03.045","article-title":"Idiosyncratic drug\u2010induced liver injury is associated with substantial morbidity and mortality within 6 months from onset","volume":"147","year":"2014","journal-title":"Gastroenterology"},{"key":"hep41064-bib-0036-20240114","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jceh.2012.05.002","article-title":"An update on drug\u2010induced liver injury","volume":"2","year":"2012","journal-title":"J Clin Exp Hepatol"},{"key":"hep41064-bib-0037-20240114","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/gutjnl-2016-313369","article-title":"Drug\u2010induced liver injury: recent advances in diagnosis and risk assessment","volume":"66","year":"2017","journal-title":"Gut."},{"key":"hep41064-bib-0038-20240114","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-0034-1375954","article-title":"Genetic basis of drug\u2010induced liver injury: present and future","volume":"34","year":"2014","journal-title":"Semin Liver Dis"},{"key":"hep41064-bib-0039-20240114","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.26077","article-title":"Human leukocyte antigen (HLA)\u2010B*57:01\u2010restricted activation of drug\u2010specific T cells provides the immunological basis for flucloxacillin\u2010induced liver injury","volume":"57","year":"2013","journal-title":"Hepatology"},{"key":"hep41064-bib-0040-20240114","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00002030-200501030-00014","article-title":"Predisposition to nevirapine hypersensitivity associated with HLA\u2010DRB1*0101 and abrogated by low CD4 T\u2010cell counts","volume":"19","year":"2005","journal-title":"AIDS"},{"key":"hep41064-bib-0041-20240114","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1053\/j.gastro.2016.12.016","article-title":"Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome\u2010wide association study","volume":"152","year":"2017","journal-title":"Gastroenterology"},{"key":"hep41064-bib-0042-20240114","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.27549","article-title":"Treatment of PD\u20101(\u2010\/\u2010) mice with amodiaquine and anti\u2010CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients","volume":"61","year":"2015","journal-title":"Hepatology"},{"key":"hep41064-bib-0043-20240114","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/liv.12988","article-title":"Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications","volume":"36","year":"2016","journal-title":"Liver Int"},{"key":"hep41064-bib-0044-20240114","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/ng.499","article-title":"Exome sequencing identifies the cause of a mendelian disorder","volume":"42","year":"2010","journal-title":"Nat Genet"}],"container-title":["Hepatology Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep4.1064","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/02009842-201708000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T16:18:13Z","timestamp":1705249093000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/02009842-201708000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,28]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1002\/hep4.1064","relation":{},"ISSN":["2471-254X","2471-254X"],"issn-type":[{"value":"2471-254X","type":"print"},{"value":"2471-254X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,28]]}}}